https://research.universityofgalway.ie/en/publications/interferon-in-the-treatment-of-progressive-hairy-cell-leukaemia-2/
Interferon in the treatment of progressive hairy cell leukaemia - University of Galway
hairy cell leukaemiathe treatmentinterferonprogressiveuniversity
https://www.njmonline.nl/article.php?i=98&d=387&a=614
Article: Hairy cell leukaemia presenting with ascites, pleural effusion and increased CA 125 serum...
hairy cell leukaemiapleural effusionarticlepresentingascites
https://www.cancerresearchuk.org/about-cancer/hairy-cell-leukaemia/research-trials
Research and clinical trials for hairy cell leukaemia | Cancer Research UK
Researchers around the world are looking into the causes and treatment of hairy cell leukaemia. Hairy cell leukaemia is rare. So there are fewer trials...
hairy cell leukaemiaclinical trialsresearchcancer
https://ecancer.org/en/video/8496-moxetumomab-pasudotox-tdfk-in-heavily-retreated-r-r-hairy-cell-leukaemia
Moxetumomab pasudotox-tdfk in heavily retreated r/r hairy cell leukaemia - ecancer
Moxetumomab pasudotox-tdfk is a first-in-class recombinant CD22-directed cytotoxin approved in the US for the treatment of adult patients with relapsed/refra
hairy cell leukaemiaheavily
https://www.clinicaltrialsarena.com/projects/moxetumomab-pasudotox-hairy-cell-leukaemia/
Moxetumomab pasudotox for the treatment of hairy cell leukaemia
Mar 1, 2023 - Moxetumomab pasudotox is an investigational anti-CD22 recombinant immunotoxin indicated for the treatment of hairy cell leukaemia (HCL) patients.
hairy cell leukaemiafor thetreatment